The lipopolysaccharide (LPS) of Pseudomonas aeruginosa PAO1 contains two species of O polysaccharide termed A and B bands. The high-molecular-weight B-band LPS determines the O specificity of the bacterium, while the antigenically distinct A-band LPS consists of only shorter-chain polysaccharides. Seven hybridomas secreting A-band-specific monoclonal antibodies were produced and used to study the Lipopolysaccharide (LPS) is a major constituent of the outer membrane of gram-negative bacteria and has essential roles in the structure and function of the membrane (14). In addition, LPS is an important virulence factor (6) and therefore has a role in pathogenesis. Heterogeneity in the size of the LPS molecule has been reported in Psezedomonas aeruginosa (5) as well as in members of the family Enterobacteriaceae (9, 18, 20) . This size heterogeneity has been attributed to variations in the number of repeating units in the O antigen. Aside from producing LPS molecules of different lengths, it also appears that some gram-negative bacteria are capable of producing LPS with chemically different polysaccharides linked to the core. These include Bordetella pertussis (4), Salmonella typhimrnuiuim (12), Salmonella paratyphi (12), and P. aeruginosa (5). In a study using P. aeruginosa PAC1, Koval and Meadow (13) 
Lipopolysaccharide (LPS) is a major constituent of the outer membrane of gram-negative bacteria and has essential roles in the structure and function of the membrane (14) . In addition, LPS is an important virulence factor (6) and therefore has a role in pathogenesis. Heterogeneity in the size of the LPS molecule has been reported in Psezedomonas aeruginosa (5) as well as in members of the family Enterobacteriaceae (9, 18, 20) . This size heterogeneity has been attributed to variations in the number of repeating units in the O antigen. Aside from producing LPS molecules of different lengths, it also appears that some gram-negative bacteria are capable of producing LPS with chemically different polysaccharides linked to the core. These include Bordetella pertussis (4), Salmonella typhimrnuiuim (12) , Salmonella paratyphi (12) , and P. aeruginosa (5) . In a study using P. aeruginosa PAC1, Koval and Meadow (13) proposed that there may be four types of LPS in a single strain: a rough LPS with an unsubstituted core polysaccharide, a smooth-rough LPS, and two long-chain LPS each with a different side chain. Recently, Rivera et al. (24) have demonstrated that P. aeruginosa PAO1 is capable of synthesizing more than one type of LPS. Analysis by gel filtration chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) revealed that the PAO1 LPS consisted of two antigenically and chemically distinct molecules termed A-and B-band LPS, respectively (24) . B band, generally composed of LPS with long-chain O antigen, is the LPS species responsible for the O specificity of the organism, while A band is composed of LPS molecules that only have short-chain polysaccharides. The two molecules are apparently antigenically different, since A-band LPS failed to react with O antigen (B-band)-specific monoclonal antibodies (MAbs).
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For the purpose of studying the structure, function, and clinical significance of A-band LPS, we have produced seven hybridomas secreting A-band-specific MAbs. Using Western immunoblotting and A-band-specific MAbs, we present data that suggest that A-band LPS is a common antigen produced by most P. aeruginosa strains and may be the major LPS antigen in nontypeable (NT) clinical strains.
MATERIALS AND METHODS
Bacterial strains and sera from patients. P. aeruginosa serotype strains O1 to 017 of the International Antigenic Typing Scheme (IATS) and their growth conditions have been described in detail previously (17) . Strain AK1401, an LPS-defective mutant of PAO1, was used to detect Aband-specific antibodies in sera from patients with cystic fibrosis (CF) (1) . Clinical strains of P. aeruginosa isolated from patients with CF and sera from patients were obtained from the State Serum Institute, Rigshospitalet, Copenhagen, Denmark. These strains were typed by using both the Pseudomonas typing sera (Difco Laboratories, Detroit, Mich.) and a set of 17 serotype-specific MAbs produced in our laboratory (16, 17) . A set of serial isolates, strains 49 to 58, was obtained from one patient with CF over a 1-month period, with samples being taken every 2 to 3 days. Serum samples from 179 patients with CF were analyzed in a dot blot assay. A group of 66 patients (mean age, 7.5 years) were not colonized with P. aeruginosa, while 113 patients (mean age. 15.9 years) had been chronically infected with P. aeruginosa for an average of 6.5 years (range, 1 to 15 years).
LPS isolation. LPS from P. aceruginosa PAO1 (IATS 05) was isolated by the method of Darveau and Hancock (7), followed by two chloroform-methanol extractions as described by Rivera et al. (24) . LPS prepared by this method was used both for screening hybridomas and for column chromatography. For (11) . LPS for dot blot analysis was also prepared by the method of Hitchcock and Brown except that bromphenol blue wàs omitted from the lysing buffer.
A-and B-band LPS isolation. The separation of PAO1 LPS by gel filtration chromatography was performed as described previously (24) . Briefly, approximately 30 mg of LPS was applied to a Sephadex G-200 (Pharmacia Fine Chemicals, Piscataway, N.J.) column (64 cm by 25 mm) and run at room temperature using a deoxycholate buffer system. Fractions (5 ml) were collected at a flow rate of 8 ml/h and were assayed for the presence of amino sugars and 2-keto-3-deoxyoctulosonic acid (24) . Pooled fractions were extensively dialyzed (using 12,000-to 14,000-molecular-weight cutoff membranes) against column buffer without deoxycholate at 37°C and then against distilled water at 4°C. The dialyzed A-and B-band fractions were then lyophilized and stored at 4°C until use.
SDS-PAGE. The discontinuous SDS-PAGE procedure of Hancock et al. (10) with 14% running gels was used. Gels were silver stained by the method of Hitchcock and Brown (11) .
MAb production and characterization. To enhance the immunogenicity of the A-band antigen, A-band LPS was mixed with bovine serum albumin in a 2:1 ratio followed by sonication at 100 W for four 30-s intervals. The immunization schedule and method for MAb production were precisely as described by Lam et al. (17) . Positive hybridoma clones were screened by an enzyme-linked immunosorbent assay as described previously (17) , using microdilution plates (Immulon 2 U plates; Dynatech Laboratories, Inc., Alexandria, Va.) coated with 0.5 ,ug of PAO1 LPS per well. The isotypes of the MAbs were determined with an enzymelinked immunosorbent assay method and a mouse typer kit (Bio-Rad Laboratories, Richmond, Calif.). The reactivities of the A-band-specific MAbs with standard serotype strains and clinical strains were examined by slide agglutination and Western immunoblotting (17) . The immunoblotting method of Burnette (3) was used but with the following modifications. Nitrocellulose blots were blocked with 1.5% gelatin (Sigma Chemical Co., St. Louis, Mo.) followed by incubation with hybridoma culture supernatant containing A-bandspecific MAbs. The blots were developed at room temperature, using a goat anti-mouse F(ab')2 fragment-alkaline phosphatase-conjugated antibody (Jackson Immunoresearch Laboratories, Inc., West Grove, Pa.) and a substrate consisting of 30 mg of Nitro Blue Tetrazolium and 15 mg of 5-bromo-4-chloro-3-indolyl phosphate toluidine in 100 ml of 0.1 M bicarbonate buffer (pH 9.8). The B-band-specific MAb, MF15-4, raised against unfractionated PAO1 LPS, and the set of serotype-specific MAbs have been described previously (17) .
Dot blot analysis of sera from patients. Dot blots were done as described by Rivera et al. (24) except that a rabbit antihuman immunoglobulin G-peroxidase-conjugated antibody (Dakopatts, Glostrup, Denmark) and a substrate consisting of 60 mg of 4-chloro-1-naphthol in 120 ml of Tris-buffered saline (20 mM Tris, 500 mM NaCI [pH 7.4]) with 16% methanol and 0.015% H202 were used. The use of an A-band-bovine serum albumin mixture appeared to be an effective immunogen, since seven hybridomas secreting A-band-specific MAbs were isolated. These were designated NlC9, Nl10, N1C6, N1G7, N1F3, N1B6, and N1E7. All seven MAbs were immunoglobulin M antibodies and had reactivity with purified LPS in the enzymelinked immunosorbent assay but failed to agglutinate PAO1 whole cells. Epitope specificity of the MAbs was determined by Western immunoblotting analysis. MAb N1C9 reacted with lower-molecular-weight bands of unfractionated LPS (Fig. 2, lane 1) and A-band LPS (Fig. 2, showed reactivity in Western immunoblots (Fig. 3) . Serotype strains 07, 012, 013, 014, 015, and 016 were not reactive with the MAbs and thus appear to lack A-band-type LPS. The reactivity of many serotype strains in Western blots is of interest because none of the serotype strains reacted with the A-band MAb in agglutination tests. The lack of agglutination reactions may be due to masking of the shorter-chain A-band LPS by the longer-chain B-band LPS molecules.
In a search for an A-band-producing reference strain, we examined a number of LPS-defective mutants and found strain AK1401 to be an A-band producer that was deficient in B-band expression. This reference strain was isolated previously (1), and preliminary data indicate that AK1401 is analogous to the S. typhimurium rfc mutants which are unable to polymerize O polysaccharides and thus lack reactivity with O-specific MAbs (data not shown). Strain AK1401, however, did react with the A-band MAb in agglutination tests and Western blots (Fig. 4, lane C) . Silver-stained gels revealed that the AK1401 LPS lacks the high-molecular-weight bands that are generally seen in the PA01 strain (Fig. 4, lanes A and B) . In addition, the spacing between these bands was similar to that of the pooled A-band fraction (Fig. 1, lane E) . Once established as an A-band reference strain, AK1401 was used to detect A-band antibody response in sera from patients with CF in subsequent experiments.
The occurrence of A-band LPS in P. aeruginosa strains isolated from patients with CF was examined by slide to contain A-band-specific antibodies since all sera agglutinated strongly with strain AK1401. Sera from three other patients with CF were also shown to contain A-band antibodies. Serum samples which contained two or more precipitin bands against standard antigen (whole-cell sonic extracts of serotypes O1 to 017) in crossed immunoelectrophoresis analysis (21) were found to agglutinate whole cells of strain AK1401 (data not shown). These data suggest that A-band polysaccharides are frequently present on the cell surface of clinical strains and can stimulate a humoral response in patients with CF.
Dot blot results of the interaction of sera from patients with CF with LPS of strain AK1401 revealed a highly significant difference (P < 0.0001) between the infected and noninfected groups of patients with respect to the reactivities of their sera with A-band LPS ( Table 2) . Analysis of variance showed that patients with positive dot blot results had significantly lower pulmonary function, higher numbers of precipitating antibodies against P. aeruginosa, increased duration of P. aerziginosa infection, and increased age than those with negative tests.
DISCUSSION
The LPS of P. aer-uginosa PAO1 was shown to consist of two different types of LPS molecules termed A and B bands.
The ability to produce heterogeneous forms of LPS in P.
aeriuginos(l was first proposed by Chester pressure of the immune system of the host against the LPS of the initial infecting strain. Presumably, the appearance of a variant strain with altered LPS antigens would provide the organism with some survival advantage. The ability of the environment to influence surface antigen properties has been observed previously (2) . Cell surface macromolecules of gram-negative bacteria undergo variation at different growth temperatures and when specific nutrients are limiting (8, 15) .
Phenotypic variation in turn affects the susceptibility of the organism to host defenses, antibiotics, and disinfectants. The exact influence that the A-band antigen has on bacterial surface properties remains to be determined. In particular, the influence of A-band LPS on surface charge distribution and the chemical nature of the A-band sugars warrant further investigation.
A-band LPS is a unique type of LPS that is antigenically different from the 0-specific B-band LPS. It is present in many standard serotype strains as well as in many clinical
isolates and therefore appears to be a common P. aeruginosa antigen. In addition, A-band LPS is the major LPS antigen in many 0-antigen-deficient NT isolates and appears to induce a humoral response in patients with CF infected by various serotype strains of P. aeruginosa. Furthermore, the appearance of A-band-specific antibodies in sera from patients can be correlated with decreased lung function and increased duration of P. aeruginosa infection. These data demonstrate the potential of using A-band polysaccharide as a vaccine 
